Dementia is common, but there are things you can do to reduce your risk or slow the progression of the disease.

A new study suggests the shingles vaccine may lower the likelihood of developing dementia as well as slow its progression in ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, drugmaker Novo Nordisk ...

Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable ...

Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral ...

It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...

Research also showed that cognitively healthy people who got the vaccine were less likely to develop mild cognitive ...

The shingles vaccine not only offers protection against the painful viral infection, but a new study suggests that the two-dose shot also may slow the progression of dementia.

Results showed that people with obesity had blood biomarkers for Alzheimer’s that rose more rapidly, including: Tau proteins, ...

The holiday season can be a stressful time for many, but for the nearly 12 million family members and friends serving as unpaid caregivers of people living with Alzheimer’s and dementia, the holidays ...

Novo Nordisk's blockbuster weight loss drug semaglutide failed to slow Alzheimer's progression in trials. The studies had been seen as a long shot.